Stocks · Health care · Services-Medical Laboratories

Quest Diagnostics

DGX Clue Score42
United States Fiscal year ends December CIK 0001022079 Results filed 22 Oct 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
2,907
$251.24
$730.35K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
2,877
$250.49
$720.65K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
3,004
$249.40
$749.21K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
2,358
$248.38
$585.69K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
1,151
$246.98
$284.28K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
5,990
$246.26
$1.48M
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
3,818
$245.45
$937.14K
Gary M Pfeiffer
26 Oct 2026
Director
Sold on a plan
1,203
$243.00
$292.33K

What was left out

Form 4 filings counted 12
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 7
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 30,185
History held since 3 Oct 2006